(Press-News.org) SAN DIEGO— Heart failure is the most common cause of death throughout the world, typically the result of chronic high blood pressure, also known as hypertension. As a result, research efforts have focused on an array of approaches aimed at preventing and treating high blood pressure. Recently, Japanese researchers examined the utility of an anti-hypertensive drug, moxonidine, which acts on the imidazoline receptors in the cardiovascular center of the brainstem. They found, using an animal model, that the drug can improve heart function and survival independent of its effect on blood pressure. They also found the drug had a favorable effect on oxidative stress, which is related to insulin resistance, the underlying abnormality in diabetes, which is common in people with heart failure.
An abstract presentation about the findings will be offered at the meeting Experimental Biology 2012, being held April 21-25 at the San Diego Convention Center. The study was conducted by Yoshitaka Hirooka, Nobuhiro Honda, Ryuichi Matsukawa, Koji Itou and Kenji Sunagawa, all of the Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences in Fukuoka, Japan. It is entitled, "Central sympathoinibition improves left ventricular function during the transition from hypertrophy to heart failure in Dahl salt-sensitive rats." The abstract is sponsored by the American Society for Investigative Pathology (ASIP), one of six scientific societies sponsoring the conference which last year attracted some 14,000 attendees.
Heart failure is a chronic disease that takes many forms and a variety of medications are used to treat it. Drugs such as ACE inhibitors and beta blockers target the causes of systolic heart failure. Clonidine, a first-generation central sympathoinhibitory drug, targets brain receptors that reduce cardiac output and lower blood pressure. Moxonidine, a second-generation drug, targets diastolic heart failure and function by reducing the effect of the central nervous system (CNS) receptors to decrease sympathetic activation and thus reduce blood pressure. In the study, salt-sensitive, hypertensive rats either received Moxonidine or were assigned to the control group. Researchers later found that the animals who received the drug had a marked inhibition of the sympathetic activity (an area of the brain) compared to those that did not. The findings suggest that inhibition of the central sympathetic outflow is important in the mechanism of hypertension. According to Dr. Hirooka, "The findings are important because they suggest that moxonidine may be useful in targeting the central receptors in the brain that are known to occur in patients with hypertension."
Next Steps
The study is the latest in a series conducted by the research team whose focus is on neural control of circulation in hypertension and heart failure. Looking ahead, they will work to identify the precise mechanisms involved in the beneficial effect of moxonidine, Dr. Hirooka said. They will also study other ways to see if the compound is a possible therapeutic tool for hypertensive heart disease to prevent heart failure. As the drug had beneficial effects on insulin resistance, they would like to further investigate the issue, he added.
Maxonidine is available in select countries in Europe and Asia. It is not currently available in the United States.
###
About Experimental Biology 2012
Six scientific societies will hold their joint scientific sessions and annual meetings, known as Experimental Biology, from April 21-25, 2012 in San Diego. This meeting brings together the leading researchers from a broad array of life science disciplines. The societies include the American Association of Anatomists (AAA), American Physiological Society (APS), American Society for Biochemistry and Molecular Biology (ASBMB), American Society for Investigative Pathology (ASIP), American Society for Nutrition (ASN), and American Society for Pharmacology and Experimental Therapeutics (ASPET). More information about the meeting can be found online at http://bit.ly/ymb7av.
About the American Society for Investigative Pathology (ASIP)
The American Society for Investigative Pathology (ASIP) is a society of biomedical scientists who investigate mechanisms of disease. Investigative pathology is an integrative discipline that links the presentation of disease in the whole organism to its fundamental cellular and molecular mechanisms. It uses a variety of structural, functional, and genetic techniques and ultimately applies research findings to the diagnosis and treatment of diseases. ASIP advocates for the practice of investigative pathology and fosters the professional career development and education of its members.
NOTE TO EDITORS: To receive a copy of the abstract or schedule an interview with a member of the research team, please contact Donna Krupa at DKrupa@the-aps.org, 301.634.7209 (office) or 703.967.2751 (cell).
END
SAN DIEGO — With more than 1.7 million people sustaining a traumatic brain injury each year, the need to identify processes to limit inflammation and subsequent damage is critical. Approximately 275,000 people are hospitalized annually with traumatic brain injury, leaving 85,000 with long-term disabilities and taking the lives of more than 50,000. More than 5 million people live with disabilities caused by traumatic brain injuries, often the result of car accidents and falls. Direct and indirect costs exceed $75 billion.
Dr. Joshua Gatson, Assistant Professor of Surgery ...
Engineers at the University of Sheffield have developed a method of assisting nerves damaged by traumatic accidents to repair naturally, which could improve the chances of restoring sensation and movement in injured limbs.
In a collaborative study with Laser Zentrum Hannover (Germany) published today (23 April 2012) in the journal Biofabrication, the team describes a new method for making medical devices called nerve guidance conduits or NGCs.
The method is based on laser direct writing, which enables the fabrication of complex structures from computer files via the ...
A research car which monitors our concentration, stress levels and driving habits while we're sat behind the steering wheel is being used to develop new technologies to support older drivers.
The Intelligent Transport team at Newcastle University, UK, have converted an electric car into a mobile laboratory.
Dubbed 'DriveLAB', the car is kitted out with tracking systems, eye trackers and bio-monitors in an effort to understand the challenges faced by older drivers and to identify where the key stress points are.
Research shows that giving up driving is one of the key ...
A small minority of today's university students don't use email and others are confused by the array of technologies available at universities. Yet many students couldn't bear to be without their mobile phones and find themselves distracted by social networking sites during study.
These are the some of the findings from research funded by the Economic and Social Research Council (ESRC) into how today's generation of students use technology. The research, led by Dr Christopher Jones of the Open University, surveyed and interviewed over two thousand first year students ...
Researchers from New York University and the Max Planck Institute in Stuttgart reveal how protons move in phosphoric acid in a Nature Chemistry study that sheds new light on the workings of a promising fuel cell electrolyte.
Phosphoric acid fuel cells were the first modern fuel cell types to be used commercially and have found application as both stationary and automotive power sources. Their high efficiency as combined power and heat generators make them attractive targets for further development. In the cell, phosphoric acid functions as the medium (or "electrolyte") ...
National Institutes of Health (NIH) scientists and their colleagues in China have described a rapidly emerging Staphylococcus aureus gene, called sasX, which plays a pivotal role in establishing methicillin-resistant S. aureus (MRSA) epidemics in most of Asia. Senior author Michael Otto, Ph.D., of NIH's National Institute of Allergy and Infectious Diseases, says these findings illustrate at the molecular level how MRSA epidemics may emerge and spread. Moreover, their study identifies a potential target for novel therapeutics.
MRSA is a leading cause of severe infections ...
The removal of skin cancer is a necessary and often life-saving procedure. There are several types of skin cancer, many of which can turn lymphatic before spreading to other areas of your body if not taken care of promptly. Because skin cancer is caused by exposure to UV rays, the face and neck are frequently impacted by these growths.
Great care is taken by your surgeon when removing skin cancer. This is in an attempt to minimize any damage to surrounding, healthy tissue, and to help ensure your cancer removal does not disfigure your features more than necessary. However, ...
CHAMPAIGN, Ill. — Through a combination of atomic-scale materials design and ultrafast measurements, researchers at the University of Illinois have revealed new insights about how heat flows across an interface between two materials.
The researchers demonstrated that a single layer of atoms can disrupt or enhance heat flow across an interface. Their results are published this week in Nature Materials.
Improved control of heat exchange is a key element to enhancing the performance of current technologies such as integrated circuits and combustion engines as well ...
On April 13, 2012, Judge Joseph R. Goodwin issued orders identifying Plaintiffs' Steering Committee for the transvaginal mesh MDL actions against manufacturing giants Johnson & Johnson, American Medical Systems, Ethicon and Boston Scientific. Select attorneys from across the country have been appointed to serve in committee and other leadership roles to coordinate the prosecution of injury claims arising from transvaginal mesh devices manufactured by these entities. Attorney Joseph A. Osborne of Babbitt Johnson Osborne & LeClainche has been selected to serve as ...
The responsibilities of a South Carolina injury lawyer extend far beyond the courtroom. We are not only advocates, but resources in our community. We possess the unique opportunity to provide the public with a great deal of information concerning their legal rights and responsibilities.
It is why I wrote the book Your Guide to South Carolina Personal Injury & Workers' Comp, and why its pages are filled with straightforward answers and safety tips rather than confusing legalese.
We are also counselors. Our job is to listen to clients' concerns, answer their questions, ...
